Sana Biotechnology (SANA) Treasury Shares (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Treasury Shares data on file, last reported at $5.1 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 14.66% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (up 14.66% YoY), and the FY2025 full-year result was $3.8 million, up 7.23% from the prior year.
• Treasury Shares rose to $5.1 million in Q1 2026, from $3.8 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $5.1 million in Q1 2026 to a low of $806000.0 in Q3 2022.
• A 5-year average of $3.0 million and a median of $3.5 million in 2025 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares plunged 86.1% in 2022 and surged 167.52% in 2024, its largest moves.
• Tracing SANA's Treasury Shares over 5 years: stood at $885000.0 in 2022, then surged by 164.52% to $2.3 million in 2023, then soared by 52.5% to $3.6 million in 2024, then climbed by 7.23% to $3.8 million in 2025, then jumped by 33.59% to $5.1 million in 2026.
• Business Quant data shows SANA's Treasury Shares at $5.1 million in Q1 2026, $3.8 million in Q4 2025, and $3.5 million in Q3 2025.